Study guide

9.2 Genitourinary Symptoms

Certified Hospice and Palliative Nurse CHPN

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Eligibility, Fees, Windows, and Retakes 1.3 Scoring, Test-Day Rules, and Remote Proctoring 1.4 Recertification: HPAR and the Situational Judgment Exercise

2 Chapter 2: Assessment, Goals, and Care Planning

2.1 Goals of Care and Shared Decision Making 2.2 Interdisciplinary Care Planning and Ongoing Evaluation 2.3 Prognostic and Functional Assessment Tools 2.4 Levels of Care and Care-Setting Transitions

3 Chapter 3: Life-Limiting Disease Progression I

3.1 Cancer, Hematologic, and Paraneoplastic Complications 3.2 Heart Failure and Cardiac Disease Progression 3.3 Pulmonary Disease Progression 3.4 Neurologic Disease Progression

4 Chapter 4: Disease Progression II and Imminent Death

4.1 Dementia, Frailty, and Feeding Decisions 4.2 Renal, Hepatic, and Endocrine Trajectories 4.3 Indicators of Imminent Death

5 Chapter 5: Pain Assessment

5.1 Pain Types, Etiology, and Syndromes 5.2 Verbal and Nonverbal Pain Assessment and Scales 5.3 Factors That Influence the Pain Experience

6 Chapter 6: Pharmacologic Pain Management

6.1 Opioid and Non-Opioid Analgesics by Pain Type and Severity 6.2 Adjuvant Analgesics 6.3 Titration, Baseline Dosing, and Breakthrough Pain 6.4 Equianalgesic Conversion and Route Changes

7 Chapter 7: Nonpharmacologic Pain and Opioid Safety

7.1 Nonpharmacologic Pain Interventions 7.2 Complementary and Integrative Pain Therapies 7.3 Opioid Adverse Effects, Neurotoxicity, and Rotation

8 Chapter 8: Neurological, Cardiovascular, and Respiratory Symptoms

8.1 Neurological Symptoms 8.2 Delirium and Terminal Restlessness 8.3 Cardiovascular Symptoms 8.4 Respiratory Symptoms: Dyspnea, Cough, and Secretions

9 Chapter 9: Gastrointestinal, Genitourinary, and Musculoskeletal Symptoms

9.1 Gastrointestinal Symptoms 9.2 Genitourinary Symptoms 9.3 Musculoskeletal Symptoms

10 Chapter 10: Skin, Metabolic, Hematologic, and Psychospiritual Symptoms

10.1 Skin and Mucous Membrane Symptoms 10.2 Nutritional and Metabolic Symptoms 10.3 Immune and Hematologic Symptoms 10.4 Psychosocial, Emotional, and Spiritual Symptom Burden

11 Chapter 11: Advance Care Planning, Benefits, and Safety

11.1 Advance Care Planning and Life-Sustaining Therapies 11.2 Hospice and Palliative Benefits under Medicare, Medicaid, and Private Insurance 11.3 Patient Safety: Environmental, Physical, and Socioemotional

12 Chapter 12: Communication, Culture, and Psychosocial Support

12.1 Communication Techniques, Barriers, and Family Meetings 12.2 Cultural Humility and Spiritual Needs 12.3 Psychosocial Needs and IDG Participation

13 Chapter 13: Caregiver Education and Medication Management

13.1 Medication Management and Controlled Substances 13.2 Caregiver and Family Self-Care 13.3 Teaching End-Stage Disease, Pain, and Symptom Plans 13.4 Caregiver Skills, DME, Supplies, and Services

14 Chapter 14: Grief, Death, and End-of-Life Ethics

14.1 Grief, Loss, and Bereavement 14.2 Support at the Time of Death and Post-Mortem Care 14.3 Ethical Issues Related to End of Life

15 Chapter 15: Medicare Hospice Compliance and National Standards

15.1 Medicare Hospice Benefit and Conditions of Participation 15.2 Hospice Eligibility, Admission, and Recertification 15.3 National Hospice and Palliative Care Standards 15.4 National Consensus Project Clinical Practice Guidelines

16 Chapter 16: Legal, Professional Practice, Quality, and Policy

16.1 Legal Regulations: CMS, HIPAA, and OSHA 16.2 Professional Boundaries and Ethics 16.3 QAPI, Self-Care, and Precepting 16.4 Policy, Delivery, and Reimbursement Trends

9.2 Genitourinary Symptoms

Key Takeaways Explain This Topic AI

Urinary retention in hospice is commonly opioids, anticholinergics, benign prostatic hyperplasia, fecal impaction, clot tamponade, or cord compression—not a mystery requiring an automatic lifelong Foley.

Upper-tract obstruction is stented or drained only when that procedure matches remaining time and goals; dying uremia is treated for comfort.

Palliative hematuria uses irrigation for clots and radiation for a bleeding tumor when prognosis fits; transfusion is a goals conversation.

Pads, condom catheters, and indwelling Foley catheters are chosen by goals, skin, retention, and dying trajectory—not by a single default device.

Oxybutynin can ease bladder spasms but is anticholinergic: watch delirium, constipation, dry mouth, and retention, especially with scopolamine.

Last updated: August 2026

9.2 Genitourinary Symptoms

Domain 3 letter E is genitourinary . Stems mix catheters, perineal skin, anticholinergic side effects, and goals of care. HPCC still wants generic names ( oxybutynin , tamsulosin , morphine ) and a scaled passing score of 500 . Catheter choice is a goals question, not a one-size protocol.

Urinary retention: name the cause before you leave a Foley

Urinary retention in hospice is usually drug-induced , outlet obstruction , constipation , clot , or neurologic .

Opioids increase sphincter tone and blunt detrusor contraction. New retention after a morphine start is not mysterious.

Anticholinergics — oxybutynin , scopolamine , tricyclic antidepressants, first-generation antihistamines, atropine-like secretion drugs—relax the detrusor. The same class you use for bladder spasms can cause retention.

Benign prostatic hyperplasia (BPH) plus an opioid or an anticholinergic is a setup. Tamsulosin (an alpha-1 blocker) may help outlet resistance when goals include voiding without a catheter.

Fecal impaction mechanically obstructs the urethra and is reversible with a bowel plan (Section 9.1).

Spinal cord compression (Chapter 8) produces overflow, a sensory level, and often bilateral weakness. Retention here is a neurologic emergency relative to remaining function if dexamethasone and imaging still match goals—not a “Foley and ignore” item.

Clot tamponade from hematuria fills the bladder with clot; the patient strains and passes little urine.

Assess with a bladder scan or in-and-out catheterization, abdominal exam, rectal exam, medication review, and a spinal screen. A single in-and-out catheter treats an isolated opioid-related episode if you also stop the offending anticholinergic and start a bowel regimen. Recurrent retention, dying with a full bladder that causes agitation, or wound-care needs may justify an indwelling urethral catheter .

Urinary obstruction above the bladder

Ureteral obstruction from cervical, prostate, or retroperitoneal disease causes hydronephrosis, flank pain, and eventually uremia. Ureteral stents or percutaneous nephrostomy reverse obstruction when the patient wants more time, dialysis-level kidney function, or relief of colic that drainage will actually treat. When death is days away, the CHPN action is comfort : treat pain, treat uremic nausea with a dopamine antagonist, treat delirium, and do not send an actively dying patient across town for a nephrostomy that will not change the dying process.

Hematuria

Palliative hematuria ranges from pink urine to clot retention and tamponade. Nursing first moves: continuous bladder irrigation to keep clots from filling the bladder, catheter care, and a calm explanation to the family that color is not always volume loss. Palliative radiation can reduce bleeding from a bladder or prostate tumor when travel, performance status, and remaining weeks make a radiation visit worth the burden. Specialist tools (alum irrigation, cystoscopic clot evacuation) exist when prognosis and goals support a procedure. Transfusion is a goals conversation: a still-ambulatory patient with symptomatic anemia may benefit; an imminently dying patient usually needs presence, dark linens, and anxiolysis more than another unit.

Fistula

Vesicovaginal , rectovaginal , and enterovesical fistulas produce odor, wetness, and devastating shame. Diversion surgery is for selected patients with months of life and reconstructable anatomy. Most hospice care is conservative : barrier films, frequent linen changes, charcoal or metronidazole for odor when bacterial overgrowth is the smell, pouching when the opening can be captured, and social-work and chaplain support. Do not promise that a Foley will dry a vesicovaginal fistula; it may reduce volume, but urine can still leak through the tract.

Incontinence, skin, and choosing a device by goals

Urine on skin macerates the sacrum and perineum and fuels fungal infection. The intervention is dryness plus barrier , not a moral lecture about “being wet.” Device choice follows goals, skin, retention, infection risk, and caregiver capacity —not staff convenience alone, and not a reflex Foley for every incontinent dying person who can still be kept dry with pads and turning.

Indwelling catheters raise infection risk. In hospice the competing harm is skin breakdown, pain, and terminal agitation from retention . Document the goal the catheter serves. A condom catheter is only for a man who is emptying the bladder; it does nothing for retention and can constrict penile skin if poorly fitted.

Decision table: pads versus condom catheter versus Foley

Clinical picture Prefer Avoid

Alert, some mobility, intact perineum, no retention Pads or briefs, scheduled toileting, barrier cream Indwelling Foley “just in case”

Man with incontinence, no retention, skin at risk from brief wetness Condom (external) catheter if it stays on and does not constrict Foley when an external device plus pads would protect skin

Retention, clot irrigation needed, open sacral wound flooded by urine, last days with agitation from a full bladder, or caregivers cannot keep skin dry Indwelling Foley (or a suprapubic catheter if already present) Leaving an 800 mL bladder because “catheters cause infection” while the patient thrashes

Dying, oliguric, family wants no extra tubes Pads, frequent changing, waterproof pads under the patient Forcing a Foley the family and patient declined

Fistula urine leaking around a catheter Skin program plus pouching; discuss whether a catheter even helps Promising dryness the anatomy cannot deliver

Bladder spasms: oxybutynin with a caution label

Bladder spasms after a catheter, with tumor in the bladder wall, or with radiation cystitis feel like sudden suprapubic cramping and urgency. Oxybutynin and related antimuscarinics reduce detrusor spasm. They also cause dry mouth, constipation, urinary retention (if a catheter is not already draining the bladder), blurred vision, heat intolerance, and delirium —especially in frail older adults and in patients already on scopolamine or a tricyclic. If spasms started after a Foley balloon inflated against a small bladder, try less balloon water or a smaller catheter before stacking anticholinergics. Belladonna-and-opium rectal suppositories appear in some protocols; they are still anticholinergic plus opioid. Non-drug checks: infection, constipation, and catheter tug on the trigone.

When retention and spasm coexist, treat the retention first. Oxybutynin on a full, undrained bladder is the wrong sequence.

Loading diagram... Goals-based urinary device choice